Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hypertension
Volume 2018 (2018), Article ID 1681056, 9 pages
https://doi.org/10.1155/2018/1681056
Clinical Study

The Association between Intradialytic Hypertension and Metabolic Disorders in End Stage Renal Disease

1Department of Nephrology, Doctors’ Hospital, Athens, Greece
2Department of Nuclear Medicine, General Hospital “Laïko”, Athens, Greece

Correspondence should be addressed to Vaia D. Raikou; rg.aou.dem@uokiarv

Received 4 November 2017; Revised 22 February 2018; Accepted 28 February 2018; Published 4 April 2018

Academic Editor: Tomohiro Katsuya

Copyright © 2018 Vaia D. Raikou and Despina Kyriaki. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. L. Bakris, J. M. Burkart, E. D. Weinhandl, P. A. McCullough, and M. A. Kraus, “Intensive hemodialysis, blood pressure, and antihypertensive medication use,” American Journal of Kidney Diseases, vol. 68, no. 5, pp. S15–S23, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Charra and C. Chazot, “Volume control, blood pressure and cardiovascular function: lessons from hemodialysis treatment,” Nephron, vol. 93, no. 4, pp. p94–p101, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Harrison, “Inflammation, immunity and hypertension,” in Journal of Hypertension, vol. 34, supplement 1, 2016, ISH 2016 Abstract Book:e535. View at Google Scholar
  4. P. A. McCullough, C. T. Chan, E. D. Weinhandl, J. M. Burkart, and G. L. Bakris, “Intensive hemodialysis, left ventricular hypertrophy, and cardiovascular disease,” American Journal of Kidney Diseases, vol. 68, no. 5, pp. S5–S14, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Ogawa, M. Koeda, and K. Nitta, “Left ventricular diastolic dysfunction in end-stage kidney disease: pathogenesis, diagnosis, and treatment,” Therapeutic Apheresis and Dialysis, vol. 19, no. 5, pp. 427–435, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Kheder-Elfekih, A. Yannoutsos, J. Blacher, G. M. London, and M. E. Safar, “Hypertension and chronic kidney disease: respective contribution of mean and pulse pressure and arterial stiffness,” Journal of Hypertension, vol. 33, no. 10, pp. 2010–2015, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. P. N. Van Buren, C. Kim, R. D. Toto, and J. K. Inrig, “The prevalence of persistent intradialytic hypertension in a hemodialysis population with extended follow-up,” The International Journal of Artificial Organs, vol. 35, no. 12, pp. 1031–1038, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. P. N. Van Buren and J. K. Inrig, “Special situations: intradialytic hypertension/chronic hypertension and intradialytic hypotension,” Seminars in Dialysis, 30, Jun 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. P. N. Van Buren, “Pathophysiology and implications of intradialytic hypertension,” Current Opinion in Nephrology and Hypertension, vol. 26, no. 4, pp. 303–310, 2017. View at Publisher · View at Google Scholar · View at Scopus
  10. M. M. Assimon and J. E. Flythe, “Intradialytic blood pressure abnormalities: the highs, the lows and all that lies between,” American Journal of Nephrology, vol. 42, no. 5, pp. 337–350, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Chauveau, H. Nguyen, C. Combe et al., “Dialyzer membrane permeability and survival in hemodialysis patients,” American Journal of Kidney Diseases, vol. 45, no. 3, pp. 565–571, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. J. T. Daugirdas, “Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error,” Journal of the American Society of Nephrology, vol. 4, no. 5, pp. 1205–1213, 1993. View at Google Scholar · View at Scopus
  13. J. K. Inrig, “Intradialytic hypertension: a less-recognized cardiovascular complication of hemodialysis,” American Journal of Kidney Diseases, vol. 55, no. 3, pp. 580–589, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. V. D. Raikou, V. Kardalinos, and D. Kyriaki, “The relationship of residual renal function with cardiovascular morbidity in hemodialysis patients and the potential role of monocyte chemoattractant protein-1,” Kidney Diseases, vol. 4, no. 1, pp. 20–28, 2018. View at Publisher · View at Google Scholar
  15. V. Raikou and D. Kyriaki, “Association between low serum bicarbonate concentrations and cardiovascular disease in patients in the end-stage of renal disease,” Diseases, vol. 4, no. 4, p. 36, 2016. View at Publisher · View at Google Scholar
  16. B. Kirschbaum, “Spurious metabolic acidosis in hemodialysis patients,” American Journal of Kidney Diseases, vol. 35, no. 6, pp. 1068–1071, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. J. T. Daugirdas, “Simplified equations for monitoring Kt/V, PCRn, eKt/V, and ePCRn,” Advances in Chronic Kidney Disease, vol. 2, no. 4, pp. 295–304, 1995. View at Publisher · View at Google Scholar · View at Scopus
  18. M. M. Assimon, L. Wang, and J. E. Flythe, “Intradialytic hypertension frequency and short-term clinical outcomes among individuals receiving maintenance hemodialysis,” American Journal of Hypertension, vol. 31, no. 3, pp. 329–339, 2018. View at Publisher · View at Google Scholar
  19. M. Cirit, F. Akçiçek, E. Terzioğlu et al., ““Paradoxical” rise in blood pressure during ultrafiltration in dialysis patients,” Nephrology Dialysis Transplantation, vol. 10, pp. 1417–1420, 1995. View at Publisher · View at Google Scholar
  20. R. Agarwal and R. P. Light, “Intradialytic hypertension is a marker of volume excess,” Nephrology Dialysis Transplantation, vol. 25, no. 10, pp. 3355–3361, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. J. E. Flythe, S. Kunaparaju, K. Dinesh, K. Cape, H. I. Feldman, and S. M. Brunelli, “Factors associated with intradialytic systolic blood pressure variability,” American Journal of Kidney Diseases, vol. 59, no. 3, pp. 409–418, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. P. N. Van Buren and J. K. Inrig, “Mechanisms and treatment of intradialytic hypertension,” Blood Purification, vol. 41, no. 1-3, pp. 188–193, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Locatelli, S. Colzani, M. D'Amico, C. Manzoni, and S. Di Filippo, “Dry weight and sodium balance,” Seminars in Nephrology, vol. 21, no. 3, pp. 291–297, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Di Filippo, C. Manzoni, S. Andrulli, F. Tentori, and F. Locatelli, “Sodium removal during pre-dilution haemofiltration,” Nephrology Dialysis Transplantation, vol. 18, pp. vii31–vii36, 2003. View at Publisher · View at Google Scholar
  25. V. D. Raikou, N. Tentolouris, D. Kyriaki, A. Evaggelatou, and H. Tzanatou, “β 2-microglobulin, pulse pressure and metabolic alterations in hemodialysis patients,” Nephron Clinical Practice, vol. 117, no. 3, pp. c237–c245, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Zheng, L.-T. Cheng, Z. Zhuang, Y. Gu, L.-J. Tang, and T. Wang, “Correlation between pulse wave velocity and fluid distribution in hemodialysis patients,” Blood Purification, vol. 27, no. 3, pp. 248–252, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. B. Di Iorio, P. Nazzaro, E. Cucciniello, and V. Bellizzi, “Influence of haemodialysis on variability of pulse wave velocity in chronic haemodialysis patients,” Nephrology Dialysis Transplantation, vol. 25, no. 5, pp. 1579–1583, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. N. Mitsides, T. Cornelis, N. J. H. Broers et al., “Extracellular overhydration linked with endothelial dysfunction in the context of inflammation in haemodialysis dependent chronic kidney disease,” PLoS ONE, vol. 12, no. 8, Article ID e0183281, 2017. View at Publisher · View at Google Scholar · View at Scopus
  29. K.-J. Chou, P.-T. Lee, C.-L. Chen et al., “Physiological changes during hemodialysis in patients with intradialysis hypertension,” Kidney International, vol. 69, no. 10, pp. 1833–1838, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. E. M. El-Shafey, G. F. El-Nagar, M. F. Selim, H. A. El-Sorogy, and A. A. Sabry, “Is there a role for endothelin-1 in the hemodynamic changes during hemodialysis?” Clinical and Experimental Nephrology, vol. 12, no. 5, pp. 370–375, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. P. A. Abraham and M. G. Macres, “Blood pressure in hemodialysis patients during amelioration of anemia with erythropoietin,” Journal of the American Society of Nephrology, vol. 2, pp. 927–936, 1991. View at Google Scholar
  32. J. K. Inrig, E. Z. Oddone, V. Hasselblad et al., “Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients,” Kidney International, vol. 71, no. 5, pp. 454–461, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. J. K. Inrig, U. D. Patel, R. D. Toto, and L. A. Szczech, “Association of blood pressure increases during hemodialysis with 2-year mortality in incident hemodialysis patients: a secondary analysis of the dialysis morbidity and mortality wave 2 study,” American Journal of Kidney Diseases, vol. 54, no. 5, pp. 881–890, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Pecoits-Filho, B. Lindholm, and P. Stenvinkel, “The malnutrition, inflammation, and atherosclerosis (MIA) syndrome—the heart of the matter,” Nephrology Dialysis Transplantation, vol. 17, supplement 11, pp. 28–31, 2002. View at Google Scholar · View at Scopus
  35. S. R. Jahromi, S. Hosseini, E. Razeghi, A. P. Meysamie, and H. Sadrzadeh, “Malnutrition predicting factors in hemodialysis patients.,” Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia, vol. 21, no. 5, pp. 846–851, 2010. View at Google Scholar · View at Scopus
  36. P. Stenvinkel, “Inflammatory and atherosclerotic interactions in the depleted uremic patient,” Blood Purification, vol. 19, no. 1, pp. 53–61, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. C. M. C. de Oliveira, C. L. D. C. Vidal, E. F. Cristino, F. M. L. Pinheiro, and M. Kubrusly, “Metabolic acidosis and its association with nutritional status in hemodialysis,” Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia, vol. 37, no. 4, pp. 458–466, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. K. Kalantar-Zadeh, R. Mehrotra, D. Fouque, and J. D. Kopple, “Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure,” Seminars in Dialysis, vol. 17, no. 6, pp. 455–465, 2004. View at Publisher · View at Google Scholar · View at Scopus
  39. N. D. Vaziri, “Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences,” American Journal of Physiology-Renal Physiology, vol. 290, no. 2, pp. F262–F272, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. V. Kovacic, L. Roguljic, and V. Kovacic, “Metabolic acidosis of chronically hemodialyzed patients,” American Journal of Nephrology, vol. 23, no. 3, pp. 158–164, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. K. M. L. Leunissen, B. W. Van den Berg, and J. P. Van Hooff, “Ionized calcium plays a pivotal role in controlling blood pressure during haemodialysis,” Blood Purification, vol. 7, no. 5, pp. 233–239, 1989. View at Publisher · View at Google Scholar · View at Scopus
  42. I. A. Checherita, C. David, A. Ciocalteu, I. Lascar, and L. Budala, “Oral treatment of metabolic acidosis in hemodialyzed patients and the implications on the hemodynamic status,” Romanian Journal of Morphology and Embryology, vol. 54, pp. 539–543, 2013. View at Google Scholar